ASCO: Biologic Agent Reduces Ovarian Cancer Relapse Risk

posted on Jun 06 by MedPage Today OB/Gyn in the Uncategorized category CHICAGO (MedPage Today) -- Maintenance therapy with a targeted agent significantly reduced the risk of relapse in women with advanced ovarian and related cancers, a researcher said here.